Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion is issuing 41,475 additional common shares through the exercise of stock options, scheduled to be listed on February 13, 2025.
📊 Key Disclosure Content & Financial Highlights
- Overview
- Company: Celltrion, Inc. (Stock Code: 068270)
- ISIN Code: KR7068270008
- Disclosure Type: Additional Listing (Exercise of Stock Options)
- Additional Listing Details
- Type and Number of Shares: Registered Common Shares 41,475 shares
- Method of Capital Increase: Exercise of Stock Options
- Issue Date: 2025-01-23
- Listing Date: 2025-02-13
- Dividend Base Date: 2025-01-01
- Issue Price per Share and Quantity by Series (Par Value: KRW 1,000)
- 150th Series: KRW 49,499 per share (16,976 shares)
- 151st Series: KRW 78,213 per share (22,899 shares)
- 152nd Series: KRW 169,828 per share (800 shares)
- 153rd Series: KRW 134,308 per share (500 shares)
- 154th Series: KRW 170,330 per share (300 shares) ※ Total Additional Shares: 41,475 shares
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Total Share Count Adjustment Following Additional Listing
This disclosure serves as official notification regarding the issuance of 41,475 new common shares resulting from stock option exercises, scheduled for listing on February 13, 2025. Verifying that the additional shares are accurately reflected in the company’s total issued and outstanding share count, as well as in subsequent periodic reporting documents, is important for tracking capital structure changes. Relevant details can be confirmed through upcoming periodic filings.
📢 Disclaimer & Source Notice
Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.
Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
